Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Coffin

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Development (Cambridge, England)|August 9, 2001
STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2M Sahni, R Raz, J D Coffin, et al.
Endothelium : Journal of Endothelial Cell Research|June 12, 1999
FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic miceD L Fulgham, S R Widhalm, S Martin, et al.
Development (Cambridge, England)|November 13, 1998
Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3M C Naski, J S Colvin, J D Coffin, et al.
Journal of Cellular Biochemistry|August 5, 2003
Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cellsL Xiao, P Liu, T Sobue, et al.
Growth, Development, and Aging : GDA|April 18, 1998
Ontogenetic limb bone scaling in basic fibroblast growth factor (FGF-2) transgenic miceP S Lightfoot, R Swisher, J D Coffin, et al.
Journal of Molecular and Cellular Cardiology|April 1, 1997
Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cellsM G Davis, M Zhou, S Ali, et al.
Journal of Cellular Biochemistry|October 24, 2007
Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null miceTakahiro Naganawa, Liping Xiao, J D Coffin, et al.
Coronary Artery Disease|October 7, 2000
Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated miceK Chiotti, S J Choo, S L Martin, et al.
The Journal of Clinical Investigation|April 20, 2000
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formationA Montero, Y Okada, M Tomita, et al.
Journal of Cellular Biochemistry|February 22, 2005
Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic miceT Sobue, T Naganawa, L Xiao, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Development (Cambridge, England)|August 9, 2001
STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2M Sahni, R Raz, J D Coffin, et al.
Endothelium : Journal of Endothelial Cell Research|June 12, 1999
FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic miceD L Fulgham, S R Widhalm, S Martin, et al.
Development (Cambridge, England)|November 13, 1998
Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3M C Naski, J S Colvin, J D Coffin, et al.
Journal of Cellular Biochemistry|August 5, 2003
Effect of overexpressing fibroblast growth factor 2 protein isoforms in osteoblastic ROS 17/2.8 cellsL Xiao, P Liu, T Sobue, et al.
Growth, Development, and Aging : GDA|April 18, 1998
Ontogenetic limb bone scaling in basic fibroblast growth factor (FGF-2) transgenic miceP S Lightfoot, R Swisher, J D Coffin, et al.
Journal of Molecular and Cellular Cardiology|April 1, 1997
Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cellsM G Davis, M Zhou, S Ali, et al.
Journal of Cellular Biochemistry|October 24, 2007
Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null miceTakahiro Naganawa, Liping Xiao, J D Coffin, et al.
Coronary Artery Disease|October 7, 2000
Activation of myocardial angiogenesis and upregulation of fibroblast growth factor-2 in transmyocardial-revascularization-treated miceK Chiotti, S J Choo, S L Martin, et al.
The Journal of Clinical Investigation|April 20, 2000
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formationA Montero, Y Okada, M Tomita, et al.
Journal of Cellular Biochemistry|February 22, 2005
Over-expression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic miceT Sobue, T Naganawa, L Xiao, et al.
Pageof 3